News from pivotal therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 09, 2014, 11:40 ET

Pivotal recibe la notificación de patente de VASCAZEN® y el inhibidor de absorción de colesterol

- Pivotal recibe la notificación de permiso de patente de Estados Unidos relacionada con la combinación de VASCAZEN® y el inhibidor...

Oct 08, 2014, 12:44 ET

Pivotal Receives Notification of Allowance for U.S. Patent Related to Combination VASCAZEN® and Cholesterol Absorption Inhibitor

WOODBRIDGE, ON, Oct. 8, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

Oct 07, 2014, 12:02 ET

Pivotal Therapeutics anuncia la notificación de permiso de patente para la aplicación de Estados Unidos 13/584,480

- Pivotal Therapeutics anuncia la notificación de permiso de patente para la aplicación de Estados Unidos 13/584,480 relacionada con la...

Oct 07, 2014, 07:00 ET

Pivotal Therapeutics Announces Notification of Patent Allowance for U.S. Application 13/584,480 Related to Combination Product of VASCAZEN® and Statin Therapy

WOODBRIDGE, ON, Oct. 7, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

Oct 03, 2014, 14:37 ET

Pivotal Therapeutics Announces Payment of Interest on Outstanding Convertible Notes

WOODBRIDGE, ON, Oct. 3, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

Sep 15, 2014, 17:42 ET

Pivotal Therapeutics Grants Incentive Stock Options

WOODBRIDGE, ON, Sept. 15, 2014 /PRNewswire/ -  Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

Sep 15, 2014, 02:07 ET

Pivotal anuncia un ensayo que muestra los efectos beneficiosos de VASCAZEN® para corregir la deficiencia de Omega-3

- Pivotal anuncia la publicación de un ensayo clínico que muestra los efectos beneficiosos de VASCAZEN® en la corrección de la...

Sep 10, 2014, 13:49 ET

Pivotal Announces Publication of a Clinical Trial Showing Beneficial Effects of VASCAZEN® In The Correction of Omega-3 Deficiency In Cardiovascular Patients

WOODBRIDGE, ON, Sept. 10, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

Sep 08, 2014, 11:50 ET

Pivotal Appoints Accomplished Healthcare and Investment Industry Veteran, Prakash Gowd, as Chief Financial Officer

WOODBRIDGE, ON, Sept. 8, 2014  /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

Sep 03, 2014, 17:55 ET

Los efectos únicos vasoprotectores y antihipertensivos de VASCAZEN® expuestos en ESC 2014

Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" o la "Compañía"), una compañía farmacéutica especializada...

Sep 03, 2014, 14:19 ET

Unique Vasoprotective and Antihypertensive Effects of VASCAZEN®'s Formulation Presented at ESC Congress 2014

WOODBRIDGE, ON, Sept. 3, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

Aug 27, 2014, 15:19 ET

Pivotal Therapeutics Announces Second Quarter Financial Results

WOODBRIDGE, ON, Aug. 27, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

Aug 20, 2014, 06:37 ET

Los datos científicos apoyan la superioridad de la formulación única Omega-3 de Pivotal

Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" o "la compañía"), una compañía farmacéutica especializada...

Aug 19, 2014, 11:03 ET

Scientific Data Supports Superiority of Pivotal's Unique Omega-3 Formulation

WOODBRIDGE, ON, Aug. 19, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

Aug 06, 2014, 12:11 ET

Pivotal Therapeutics To Explore Potential Commercial Partnership Opportunities in China

WOODBRIDGE, ON, August 6, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

Jun 11, 2014, 10:34 ET

Pivotal Therapeutics engages Kilmer Lucas for cross-border investor relations

WOODBRIDGE, ON, June 11, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty...

May 30, 2014, 16:38 ET

Pivotal Therapeutics Announces First Quarter Financial Results

WOODBRIDGE, ON, May 30, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF) (CSE:PVO), ("Pivotal" or the "Company"), a specialty...

May 14, 2014, 19:28 ET

Pivotal Therapeutics announces changes to the Board of Directors

WOODBRIDGE, ON, May 14, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF)(CSE:PVO) ("Pivotal" or "the Company"), a specialty...

May 13, 2014, 13:51 ET

Pivotal Therapeutics Engages Brandkarma LLC.

WOODBRIDGE, ON, May 13, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on...

May 07, 2014, 11:39 ET

Pivotal Therapeutics announces issuance of U.S. Patent 8,715,648 for its unique 6:1 EPA:DHA formulation

WOODBRIDGE, ON, May 7, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a...